Medtronic (MDT) EPS (Weighted Average and Diluted) (2014 - 2026)

Medtronic has disclosed EPS (Weighted Average and Diluted) across 13 years of filings, most recently posting $0.89 for Q1 2026.

• EPS (Weighted Average and Diluted) for Q1 2026 came in at $0.89, down 11.88% year-over-year; the trailing twelve-month figure through Jan 2026 was $3.59 (up 9.12% YoY), and the FY2025 annual result was $3.61, up 30.8% from the prior year.
• EPS (Weighted Average and Diluted) came in at $0.89 for Q1 2026 at Medtronic, down from $1.07 in the prior quarter.
• In the past five years, EPS (Weighted Average and Diluted) ranged from a high of $1.1 in Q1 2022 to a low of $0.32 in Q4 2022.
• The 5-year median for EPS (Weighted Average and Diluted) is $0.88 (2023), against an average of $0.83.
• Across the five-year window, EPS (Weighted Average and Diluted) slumped 67.01% in 2022 and soared 112.5% in 2023, its largest moves.
• Medtronic's EPS (Weighted Average and Diluted) stood at $0.32 in 2022, then jumped by 112.5% to $0.68 in 2023, then surged by 45.59% to $0.99 in 2024, then increased by 8.08% to $1.07 in 2025, then fell by 16.82% to $0.89 in 2026.
• The last three EPS (Weighted Average and Diluted) figures came in at $0.89 (Q1 2026), $1.07 (Q4 2025), and $0.81 (Q3 2025), per Business Quant data.